Literature DB >> 25401465

Special delivery: microRNA-200-containing extracellular vesicles provide metastatic message to distal tumor cells.

David M Epstein.   

Abstract

An emerging view is that breast cancer is a systemic disease that utilizes intrinsic and extrinsic tumor cell processes to support both primary tumor growth and metastatic dissemination into distal tissue. Delineation of factors involved in these processes should facilitate a better understanding for both assessing and preventing disease relapse. In this issue of the JCI, Le et al. investigate whether intrinsic properties of metastatic breast cancer cell growth can be regulated through an extrinsic process--contact with tumor cell-derived extracellular vesicles containing microRNAs of the miR-200 family. The authors provide compelling evidence that miR-200s within extracellular vesicles secreted from highly metastatic tumor cells can be internalized by weakly metastatic cells. Thus, internalization and delivery of this metastatic "donor" cell-derived message provide plausible mechanisms by which oncogenic and regulatory factors confer the capability of tumor growth at metastatic lesions. This study provides a strong rationale for detailed assessment of the prognostic and predictive value of circulating extracellular vesicle-bound miR-200s in breast cancer progression and treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25401465      PMCID: PMC4348972          DOI: 10.1172/JCI79191

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  miR-200-containing extracellular vesicles promote breast cancer cell metastasis.

Authors:  Minh T N Le; Peter Hamar; Changying Guo; Emre Basar; Ricardo Perdigão-Henriques; Leonora Balaj; Judy Lieberman
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

2.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Authors:  Héctor Peinado; Maša Alečković; Simon Lavotshkin; Irina Matei; Bruno Costa-Silva; Gema Moreno-Bueno; Marta Hergueta-Redondo; Caitlin Williams; Guillermo García-Santos; Cyrus Ghajar; Ayuko Nitadori-Hoshino; Caitlin Hoffman; Karen Badal; Benjamin A Garcia; Margaret K Callahan; Jianda Yuan; Vilma R Martins; Johan Skog; Rosandra N Kaplan; Mary S Brady; Jedd D Wolchok; Paul B Chapman; Yibin Kang; Jacqueline Bromberg; David Lyden
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

3.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

Authors:  Sun-Mi Park; Arti B Gaur; Ernst Lengyel; Marcus E Peter
Journal:  Genes Dev       Date:  2008-04-01       Impact factor: 11.361

4.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.

Authors:  Philip A Gregory; Andrew G Bert; Emily L Paterson; Simon C Barry; Anna Tsykin; Gelareh Farshid; Mathew A Vadas; Yeesim Khew-Goodall; Gregory J Goodall
Journal:  Nat Cell Biol       Date:  2008-03-30       Impact factor: 28.824

5.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

Authors:  Weiying Zhou; Miranda Y Fong; Yongfen Min; George Somlo; Liang Liu; Melanie R Palomares; Yang Yu; Amy Chow; Sean Timothy Francis O'Connor; Andrew R Chin; Yun Yen; Yafan Wang; Eric G Marcusson; Peiguo Chu; Jun Wu; Xiwei Wu; Arthur Xuejun Li; Zhuo Li; Hanlin Gao; Xiubao Ren; Mark P Boldin; Pengnian Charles Lin; Shizhen Emily Wang
Journal:  Cancer Cell       Date:  2014-04-14       Impact factor: 31.743

6.  Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.

Authors:  Dharanija Madhavan; Manuela Zucknick; Markus Wallwiener; Katarina Cuk; Caroline Modugno; Martina Scharpff; Sarah Schott; Jörg Heil; Andrey Turchinovich; Rongxi Yang; Axel Benner; Sabine Riethdorf; Andreas Trumpp; Christof Sohn; Klaus Pantel; Andreas Schneeweiss; Barbara Burwinkel
Journal:  Clin Cancer Res       Date:  2012-09-04       Impact factor: 12.531

7.  Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Authors:  Manav Korpal; Brian J Ell; Francesca M Buffa; Toni Ibrahim; Mario A Blanco; Toni Celià-Terrassa; Laura Mercatali; Zia Khan; Hani Goodarzi; Yuling Hua; Yong Wei; Guohong Hu; Benjamin A Garcia; Jiannis Ragoussis; Dino Amadori; Adrian L Harris; Yibin Kang
Journal:  Nat Med       Date:  2011-08-07       Impact factor: 53.440

8.  MicroRNA expression characterizes oligometastasis(es).

Authors:  Yves A Lussier; H Rosie Xing; Joseph K Salama; Nikolai N Khodarev; Yong Huang; Qingbei Zhang; Sajid A Khan; Xinan Yang; Michael D Hasselle; Thomas E Darga; Renuka Malik; Hanli Fan; Samantha Perakis; Matthew Filippo; Kimberly Corbin; Younghee Lee; Mitchell C Posner; Steven J Chmura; Samuel Hellman; Ralph R Weichselbaum
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

Review 9.  Origins of metastatic traits.

Authors:  Sakari Vanharanta; Joan Massagué
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

10.  Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer.

Authors:  Kelly A Avery-Kiejda; Stephen G Braye; Andrea Mathe; John F Forbes; Rodney J Scott
Journal:  BMC Cancer       Date:  2014-01-31       Impact factor: 4.430

View more
  7 in total

1.  Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes.

Authors:  Shweta Bhatt; Manoj K Gupta; Mogher Khamaisi; Rachael Martinez; Marina A Gritsenko; Bridget K Wagner; Patrick Guye; Volker Busskamp; Jun Shirakawa; Gongxiong Wu; Chong Wee Liew; Therese R Clauss; Ivan Valdez; Abdelfattah El Ouaamari; Ercument Dirice; Tomozumi Takatani; Hillary A Keenan; Richard D Smith; George Church; Ron Weiss; Amy J Wagers; Wei-Jun Qian; George L King; Rohit N Kulkarni
Journal:  Cell Metab       Date:  2015-08-04       Impact factor: 27.287

2.  A Fleeting Glimpse Inside microRNA, Epigenetics, and Micropeptidomics.

Authors:  Gaetano Santulli
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 3.  Signaling by exosomal microRNAs in cancer.

Authors:  Germana Falcone; Armando Felsani; Igea D'Agnano
Journal:  J Exp Clin Cancer Res       Date:  2015-04-02

4.  All-trans retinoic acid reverses malignant biological behavior of hepatocarcinoma cells by regulating miR-200 family members.

Authors:  Jiejie Cui; Mengjia Gong; Shuyu Fang; Chaoqun Hu; Yi Wang; Jingfang Zhang; Ni Tang; Yun He
Journal:  Genes Dis       Date:  2020-01-10

5.  Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.

Authors:  Tian Fang; Hongwei Lv; Guishuai Lv; Ting Li; Changzheng Wang; Qin Han; Lexing Yu; Bo Su; Linna Guo; Shanna Huang; Dan Cao; Liang Tang; Shanhua Tang; Mengchao Wu; Wen Yang; Hongyang Wang
Journal:  Nat Commun       Date:  2018-01-15       Impact factor: 14.919

Review 6.  MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages.

Authors:  Graziella Curtale
Journal:  Cells       Date:  2018-02-08       Impact factor: 6.600

7.  Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer.

Authors:  Xin Wang; Tianyi Qian; Siqi Bao; Hengqiang Zhao; Hongyan Chen; Zeyu Xing; Yalun Li; Menglu Zhang; Xiangzhi Meng; Changchang Wang; Jie Wang; Hongxia Gao; Jiaqi Liu; Meng Zhou; Xiang Wang
Journal:  Mol Oncol       Date:  2021-06-25       Impact factor: 6.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.